FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment

The experimental cocktail from the biotech company Regeneron is the same drug President Trump got when he was battling the coronavirus this year. It is designed for mild to moderate cases.

(Image credit: Susan Walsh/AP)

Source link